Kinarus Therapeutics (SIX:KNRS)
About:
Kinarus is focused on developing novel treatments for patients suffering from serious viral, respiratory, and ophthalmic diseases.
Website: https://www.kinarus.com/
Top Investors: Chaodian Culture, Yorkville Advisors
Description:
Kinarus is a biopharmaceutical company that develops differentiated medicines in areas of stress related inflammatory processes based on cross disease area target assessment.
Total Funding Amount:
36.6M CHF
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Basel, Basel-Stadt, Switzerland
Founded Date:
2017-09-01
Contact Email:
matthew.wright(AT)kinarus.com
Founders:
Alexander Bausch
Number of Employees:
1-10
Last Funding Date:
2023-05-11
IPO Status:
Public
Industries:
© 2025 bioDAO.ai